View Article

Abstract

Clarithromycin is an antibiotic, mainly used to cure chest infections such as pneumonia, ear infections and skin problems such as cellulitis. It's also used to treat Helicobacter pylori, bacteria that can cause stomach ulcers. It has low absorption of oral bioavailability and high absorption in the upper part of GIT. The GRDDS is able to prolong the retentive time of a dosage form in the stomach, thereby improving the oral bioavailability of the drug. The aim of this study is to formulate floating tablets of Clarithromycin using synthetic and natural polymers by direct compression method and to evaluate the formulation for various pharmaceutical parameters. The plan of work is carried out the pre-formulation studies(Organoleptic properties, Solubility), formulation of floatable tablet by using direct compression method and evaluation of floatable tablet(Thickness, Hardness, Friability, Weight variation, In vitro buoyancy test, Swelling Index, Assay, In vitro dissolution studies).

Keywords

Floating tablet, Gastro retentive, Helicobacter pylori, HPMC

Introduction

Oral administration is the most convenient and preferred method for delivering drugs to systemic circulation. Recently, oral controlled release drug delivery has gained interest in the pharmaceutical field due to its therapeutic benefits, including simplified dosing, improved patient compliance, and formulation flexibility. However, drugs that are rapidly absorbed from the gastrointestinal tract and have short half-lives are quickly eliminated from systemic circulation.

Gastro retentive drug delivery systems (GRDDS) extend the retention time of dosage forms in the stomach, enhancing oral bioavailability. These systems provide continuous drug release before the absorption window, supporting optimal bioavailability. The primary advantage of GRDDS is maintaining consistent drug levels over an extended period, making it suitable for sustained drug delivery. Because drug absorption in the gastrointestinal tract is highly variable, prolonging gastric retention increases the time available for absorption. Floating drug delivery systems (FDDS) offer a promising approach for gastric retention.

This approach is particularly advantageous for drugs such as clarithromycin, which is frequently employed in the treatment of infections caused by Helicobacter pylori (H. pylori). Effective therapy for these infections requires prolonged drug contact with the stomach lining. H. pylori, a spiral-shaped, gram-negative bacterium, are a primary cause of chronic gastritis, peptic ulcers, and more severe conditions including gastric cancer and mucosa-associated lymphoid tissue (MALT) lymphoma.

MATERIALS AND METHODS

MATERIALS

The chief material Clarithromycin and HPMC K100M were provided by Micro-labs limited, Hosur. Locust Bean Gum was purchased from Sha Narendra and Sons, Chennai. Sodium bicarbonate was purchased from SRL private limited Chennai.  Microcrystalline Cellulose was purchased from Yarrow chem product, Mumbai. Magnesium stearate was purchased from Isochem Laboratories, Kochi and Talc was purchased from Spectrum Reagents and Chemicals,

METHODOLOGY

Calibration Curve Of Clarithromycin

Preparation of 0.1 N HCL Solutions:

8.4 ml of concentrated HCL solution was taken in volumetric flask and made up with 1000 ml of distilled water.

Preparation of Standard curve of Clarithromycin:

10 mg of clarithromycin pure drug was dissolved in 10ml of methanol. From this stock solution, 1ml of solution was taken and made up with 10 ml of 0.1N HCL .From here 1 ml was taken and composed with 10 ml of 0.1 N HCL (10µg / ml ).

Aliquoted  the portion of the above solution containing 2, 4, 6, 8, 10µg/ml by using 0.1N HCL. The absorbance of resultant solution was measured at 210 nm by using UV Spectrophotometer taking 0.1 N HCL as blank.

Then plotted a graph of concentration on the x-axis and absorbance on the y-axis, which gives a straight line. Linearity of standard curve was evaluated from the square of correlation coefficient (R²) which determined by least square y= mx + c method of analysis.

Table 1:  Standard Calibration Curve Data of Clarithromycin

S.no

Concentration (µg/ ml )

Absorbance at 210 nm

1.

0

0

2.

2

0.0553

3.

4

0.122

4.

6

0.1789

5.

8

0.2353

6.

10

0.26

Standard Calibration Curve of Clarithromycin

Figure 1: Standard Curve of Clarithromycin

Preformulation Studies:

Pre-formulation can be defined as an investigation of physical and chemical properties of drug substance alone and when combined with excipients. It is the first step in the rational information useful to the formulator in developing stable and bioavailable dosage forms. The use of pre-formulation parameter maximizes the chances in formulating acceptable, safe, efficacious and stable product. It is one of the important prerequisite in development of any drug delivery system. Pre formulation studies were performed on the drug, which included solubility, melting point, flow properties, compatibility studies.

Organoleptic Properties

The organoleptic properties like color, odor and taste of API were evaluated.

  1. Color: A small quantity of clarithromycin was taken in a butter paper and viewed in well illuminated place
  2. Odor: Very small quantity of clarithromycin was smelled with the help of nose to get odor
  3. Taste: A small quantity of clarithromycin was used to taste with the help of tongue 

Solubility Test:

Assessing the solubility of clarithromycin in ethanol, methanol, acetone and methylene chloride in a test tube and in water. When 10 mg of the medication is taken with 2ml of water ethanol, methanol, acetone, and methylene chloride, the drug's solubility is indicated as being Soluble, slightly soluble.

Evaluation Of Precompression Parameters

Micrometric Properties

Angle Of Repose

The frictional forces in a loose powder or granules can be measured by angle of repose. This is the maximum angle possible between the surface of a pile of powder or granules and the horizontal plane. The powders were allowed to flow through the funnel fixed to a stand so that the lower tip of the funnel was 2.5cm above the surface; a graph paper was placed on a flat surface. The blend was allowed to fall freely on the graph paper through the funnel till the tip of the heap formed just touches the funnel. The height and radius of the heap was noted and from this angle of repose was determined by using following formula,

tan θ = h/r

θ= tan-?(h/r)

where       θ= angle of repose.

 h= height of the pile in cm

 r= radius of the pile in cm.

Bulk Density

The term bulk density refers to a measure used to describe a packaging of particles. It was determined by using a balance and measuring cylinder. Initially the weight of the measuring cylinder was tarred. Then 4g pre-sieved bulk drug were poured into the measuring cylinder using a funnel. Then volume of the powder was taken. Bulk density of the powder was calculated using following formula.

Bulk density = Weight of the powder  Volume occupied by the powder

tapped density

Tapped density was determined by placing a graduated cylinder containing same mass of powder used for bulk density on a mechanical tapper apparatus which is operated for a fixed number of taps (approx100) until powder bed volume has reached a minimum.

Bulk density = Weight of the powder Tapped Volume of powder  

Compressibility Index

Compressibility of a powder can be defined as the ability to decrease in volume under pressure and compatibility as the ability of the powdered material to be compressed into a tablet of specified tensile strength. It can be used to predict the floe properties based on density measurement.

Bulk density = Tapped density-Bulk density Tapped density  ×100

Hausner’s Ratio:

Hausner’s ratio is also used the measure the porosity and the flow ability of the powder. It can be calculated from the bulk and tapped density. Hausner’s ratio is calculated by using the formula

Hausner's ratio = Tapped density Bulk density

Scale Of Flowability:

Table 3:  Scale of Flow ability

Flow Character

Angle of Repose

Compressibility Index (%)

Hausner’s Ratio

Excellent

25-30

<10

1.0-1.1

Good

31-35

11-15

1.12-1.18

Fair

36-40

16-20

1.19-1.25

Passable

41-45

21-25

1.26-1.34

Poor

46-55

26-31

1.35-1.45

Very Poor

56-65

32-37

1.46-1.59

Extremely Poor

>66

>38

>1.60

Fourier Transform Infra-Red Spectroscopy (FTIR):

FTIR spectra for pure drug, physical mixture and optimized formulations were recorded using a Fourier transform Infrared spectrophotometer. The analysis was carried out in Shimadzu-IR Affinity spectrophotometer. The samples were dispersed in KBr and compressed into disc / pellet by application of pressure. The pellets were placed in the light path for recording the IR spectra. The scanning range was 4000 cm-1 the resolution was 1cm -1.

Formulation Of Clarithromycin Floating Tablets By Direct Compression Method

Floating tablets of clarithromycin were prepared by direct compression method.

Direct Compression Method:

Sieving: The active ingredient was passed through the sieve # 40. The other ingredients given in the formulation table were passed separately through the same sieve. Dry mixing all the materials (including the active ingredient) were taken in poly bag and mixed for 10 minutes.

Lubrication: The magnesium stearate was passed through the sieve #60 and mixed together with the powder in a poly bag for 5 minutes to get a uniform blend.

Compression: Finally, the tablet blend was compressed into tablets by using 16 station rotary tablet press which contains punch size of 11 mm in diameter.

Composition Of Clarithromycin Floating Tablets

Table 4: Composition of Clarithromycin Floating tablets

Ingredients

F I

F ?

F ?

Clarithromycin

250 mg

250mg

250 mg

HPMC K100

100mg

-

25mg

Locust bean gum

-

100mg

75mg

Sodium bicarbonate

75mg

50mg

75mg

Microcrystalline Cellulose

60mg

85mg

60mg

Magnesium stearate

7.5mg

7.5mg

7.5mg

Talc

7.5mg

7.5mg

7.5mg

Total

500mg

500mg

500mg

Post Compression Parameters

The compressed tablets were evaluated for the following parameters.

General Appearance

The tablet should be free from cracks, depressions, pinholes etc. The color and polish of the tablets should be uniform on whole surface. The surface of the tablets should be smooth. The tablets were examined externally under a biconvex lens for surface cracks depression and pinholes.

Hardness Test

The strength of a tablet to stand against applied load /pressure is known as hardness. It is also known as crushing strength. Randomly take 5-10 tablets from prepared batch and hardness should be determined by crushing the tablet by hardness tester and then find out the average and standard deviation. Hardness is determined by using hardness tester (Monsanto). The value of hardness was calculated in kg/cm².

Thickness

Twenty tablets from the sample were randomly taken and individual tablet thickness was measured using digital Vernier caliper. Average thickness and standard deviation values were calculated. The thickness was denoted in mm.

Friability

Friability is to measure the extent of tablet breakage during physical stress conditions like packaging, transportation etc. A sample of randomly selected 6 tablets was evaluated for friability using Roche friabilator at 25 rpm for minutes. The % weight loss is calculated by measuring the total weight of 6 tablets before and after operation. Formula for calculating the % weight loss is given below.

%Friability = Initial Weight - Final weight    Initial Weight  ×100  

Weight Variation Test

To study weight variation 20 tablets of each formulation were weighed using an electronic balance, average weights was calculated, individual tablet weights were compared with the average weight. Not more than two individual weights deviate from the average weight by more than the percentage deviation and none should deviate by more than twice that percentage.

%Deviation= Average  Weight -tablet weight Average Weight  ×100

Table 5: Weight Variation of Tablet and Percentage Deviation

Average weight of tablets (mg) in I. P.

Percentage deviation

80 or less

±10

More than 80 but less than 250

±7.5

More than 250

± 5

Drug Content of Clarithromycin:

The drug content in each formulation was determined by weighing randomly selected tablets pulverizing to a fine powder and powder equivalent to 10 mg of clarithromycin was weighed and dissolved in 10 ml of methanol in volumetric flask using magnetic stirrer, the volume was adjusted to 100ml with 0.1 N HCL. The solution was filtered through a 0.45 µ membrane filter, An aliquot of 1ml solution were diluted to 10 ml of 0.1 N HCL in separate volumetric flask. The absorbance of resultant solution was measured by using UV Visible Spectrophotometer at 210 nm using 0.1N HCL as blank.

In-Vitro Buoyancy Studies:

The In-vitro buoyancy was characterized by floating lag time and total floating time. As per the method described by Rosa et al, the tablets were placed in a 100 ml beaker containing 0.1 N HCL, which was determined at 37°C. The time required for the tablet to rise to the surface of the medium was determined as the buoyancy lag time or floating lag time. The duration of which the dosage form constantly remained on the surface of medium was determined as the total buoyancy time or total floating time.

Swelling Index:

The swelling behavior of a dosage unit was measured by studying its weight gain. The swelling index of tablet was determined by placing the tablets in a beaker containing 250 ml of 0.1 N HCL at 37±0.5°C. The tablets were removed from every one hour from the medium. After draining free water by blotting with tissue paper, these were weighed for weight gain on the analysis balance. Swelling index (SI) was calculated by using following formula;

SI=    Weight of tablet at time-Weight of tablet before immersion  Weight of Tablet before immersion   ×100

In-Vitro Dissolution Studies:

USP 32 (Apparatus 2) paddle method. The dissolution test was performed with 900 ml of 0.1 N HCL, at 37°C and rotated speed at 50 rpm. The test duration was 12 hours. Sampling was carried out after 0.5 hour and then at hourly intervals. A 5ml sample of the solution was withdrawn and replaced with fresh dissolution medium to maintain sink conditions. The filtered samples were diluted with suitable volume of 0.1 N HCL and absorbance of 210nm using UV-Visible spectrophotometer.

RESULTS AND DISCUSSION

Preformulation Studies

Organoleptic Properties:

The Organoleptic properties of Clarithromycin was given in the below table

Table 6: Organoleptic Properties

Tests

Specification

Observation

Color

White

White

Odor

Odorless

Odorless

Taste

Bitter

Bitter

Solubility Test

Table 7:  Solubility Profile of Clarithromycin

Clarithromycin (API)

Solubility

Clarithromycin

Soluble in acetone and methylene chloride, slightly soluble in alcohol, methanol and acetonitrile.

FTIR Spectral Studies:

The FT-IR studies are carried out for pure clarithromycin raw material, Natural polymer (Locust bean gum) and Synthetic polymer ( HPMC K100) and combination of drug and natural polymer and synthetic polymer were carried out to find any interaction between drug and excipients used in the formulation. This study was carried out by IR Spectroscopy (SHIMADZU). The results are given below,

Table 8:  FT-IR Spectral Data of Pure Clarithromycin

S. No

Wave number(cm??)

Functional group

1

2970

O-H Stretching

2

1689

C=O Stretching

3

1373

C-H Stretching

4

1056

C-O Stretching

5

894

C-H Bending

Table 9:  FT-IR Spectral Data of HPMC K100

S.No

Wave number (cm??)

Functional Group

1

2931

O-H Stretching

2

1635

C=O Stretching

3

1381

C-H Bending

4

1064

C-O Stretching

5

941

C-H Bending

Table 10:  FT-IR Spectrum of Locust Bean Gum

S. No

Wave number (cm??)

Functional group

1

2924

O-H Stretching

2

1666

C=O Stretching

3

1381

C-H Bending

4

1072

C-O Stretching

5

871

C-H Bending

Table 11: FT-IR Spectrum Data of Clarithromycin + HPMC K100

S. No

Wave number (cm??)

Functional group

1.

2978

O-H Stretching

2.

1689

C=O Stretching

3.

1373

C-H Bending

4.

1049

C-O Stretching

5.

910

C-H Bending

Table 12: FT-IR Spectral Data of Clarithromycin + Locust Bean Gum

S. No

Wave number (cm??)

Functional group

1.

2970

O-H Stretching

2.

1689

C=O Stretching

3.

1373

C-H Bending

4.

1049

C-O Stretching

5.

894

C-H Bending

Table 13:  FT-IR Spectral Data of Clarithromycin+ HPMC K100 + Locust Bean Gum

S.No

Wave Number (cm??)

Functional Group

1.

2976

O-H Stretching

2.

1689

C=O Stretching

3.

1381

C-H Bending

4.

1069

C-O Stretching

5.

887

C-H Bending

DISCUSSION: The FT-IR spectral studies show that the drug is compatible with all the excipients. The FT-IR spectrum of physical mixture shows all the characteristic peaks of Clarithromycin, thus confirming that no interaction of drug occurred with the components of the formulation.

Pre Compression Parameters

Micrometric Properties

The powder blends are evaluated for the micrometric properties such as angle of repose, bulk density, tapped density, compressibility index and hausner’s ratio. The results are given in the below table.

Table 14:  Pre-Compression Parameters

Formulation code

Angle of repose

Bulk density

g/cm?

Tapped density

g/cm?

Compressibility index (%)

Hausner’s ratio

F ?

24°39’

0.468

0.521

9.9

1.101

F ?

24°19’

0.471

0.528

9.5

1.105

F ?

25°66’

0.465

0.518

9.2

1.100

DISCUSSION:

The angle of repose of Formulation ? &? was found to be 24°39’ and 24°19’ which indicates excellent flow property and angle of repose of Formulation ? was found to be 25°66’ which indicates good flow property. The bulk density was found to be between 0.465 to 0.471 g/cm ?, tapped density was found to be between 0.518 to 0.528 g/cm ?, the compressibility index was found in the range of 9.2 to 9.9 % and the Hausner’s ratio lies between 1.100 to 1.105.The above results in the term of micrometric properties reveals that the flow property of Formulation ?, ?, ? was excellent and good.

Post Compression Parameters

General Appearance

Table 15: General Appearance of the Formulations

Color

White

Shape

Round

Surface

Smooth

Cracks, Depressions, Pinholes

Absent

Other Parameters

Table 16: Post Compression Parameters

Formulation Code

Weight Variation(mg)

Hardness

(Kg/ cm²)

Friability (%)

Thickness (mm)

Formulation ?

480±5.44

6.2

0.19

5.16

Formulation ?

480±5.58

6.4

0.33

5.15

Formulation ?

487±5.10

6.4

0.16

5.14

 

Standard as per IP limit

6.2 to 6.4 kg/cm ²

less than 1%

5.14 - 5.16mm

Table 17: Swelling Index of Clarithromycin

Time (HRS)

F I

F II

F III

1

30

32

29

2

46

48

44

3

61

64

61

4

80

82

79

5

92

95

90

The Swelling Percentage of clarithromycin tablets was found in the range between 90 to 95%.

Invitro Buoyancy

Test

Figure 8: In-Vitro Buoyancy Test

Assay Of Clarithromycin by UV Spectroscopy Method

The assay of clarithromycin floating tablets was done by UV spectroscopy method as per the procedure given in the methodology. The assay values of the clarithromycin floating tablets are given in the below table.

Table 19: Assay of Clarithromycin by UV method

Formulation Code

Assay (%)

Formulation-I

90.28%

Formulation –II

103%

Formulation-III

93.98%

DISCUSSION

The assay of clarithromycin floating tablets was found in the range between 90.28% and 103%. As per I.P. the acceptable limit of the clarithromycin floating tablets is90 to110%. The above results revealed that the assay of Clarithromycin was within the acceptable limit(90-110%)s.

In Vitro Dissolution Studies

The In Vitro drug release of the clarithromycin floating tablets were given in the table

Table 20:  In-vitro dissolution release of clarithromycin floating tablets

Time (minutes)

F-I

F-II

 

F-III

30

19.59

14.58

16.54

60

29.98

21.4

29.7

90

39.98

29.63

36.82

120

48.64

36.59

42.62

150

56.12

41.68

51.98

180

61.73

46.46

58.32

210

68.68

51.31

64.43

240

74.31

59.26

68.81

270

81.69

65.3

73.59

300

88.17

71.42

78.61

330

91.11

78.36

86.59

360

96.71

86.78

93.06

Percentage Drug Release of Clarithromycin Floating Tablet

Figure 9: In-vitro Drug Release of Clarithromycin Floating Tablets

DISCUSSION

The release of clarithromycin was studied up to 6 hours. The Formulation F-I (HPMC K100), F-II (Locust Bean Gum) and F-III (HPMC K100 + Locust Bean Gum) were prepared with MCC, Magnesium stearate and Talc.

The Drug release of F-I ,F-II ,F-III was found to be 96.71%, 86.78%, 93.06% at 360 minutes.

The acceptable limit of in-vitro dissolution is NLT 50% of the drug release at 360 minutes. All the formulations are passed the in-vitro dissolution studies. The better drug release was observed in F-II using Locust Bean Gum as a polymer due to controlled drug release and prolonged onset of action.

CONCLUSION

From this study, the overall results revealed that the Formulation F-I (HPMC K100) and F-III (HPMC K100 and Locust Bean Gum) gives better results when compared to other F-II. Despite that, F-II (Locust Bean Gum) which gives prolonged drug release. The work concluded that the Clarithromycin Floating Tablets could be successfully formulated by direct compression method using synthetic and natural polymer in different concentration. The Formulation F-II which contains Locust Bean Gum as natural polymer which gives delayed dissolution rate, provides convenience administration, patient compliance, therapeutic effectiveness and which effectively treat peptic ulcer caused by Helicobacter Pylori with less side effect compared to synthetic polymer. From the above observation, it was concluded that the Formulation F-II containing natural polymer (Locust Bean Gum) was found to be better one compared to other formulations.

REFERENCES

  1. Arifa Begum S.K, Basavu Raju. Formulation Development and Evaluation of Cimetidine floating microspheres. International Journal of Pharma Tech Research. 2013 9(2),182-192.
  2. Ashish Garg, Gupta M.M. Mouth Dissolving Tablets. Journal of Drug Delivery and Therapeutics. 2013, 3(2), 207-214.
  3. Burns SJ. Altwood D, Barnwell SG. Assessment of a Dissolution Vessel Designed for Use with Floating and Erodible Dosage Forms. Int. J. Pharm. 1998, 160,213-218.
  4. Chawla G, Gupta P, Koradia V, Bansal A. Gastroretention: A means to address regional Variability in intestinal drug abosorption. Pharm. Tech. 2003, 50-68.
  5. Chowdary K.P.R, Galibsaheb V. Asian Journal of Chemistry. 2010,22(7), 5277-5281.
  6. Dave B.S, Amin A.F. Patel M.M. Gastroretentive Drug Delivery System of Ranitidine HCI Formulation and In-Vitro Evaluation AAPS Pharm. Sci. Tech. 2004,5(2),1-6.
  7. Dehdari S, Dabirsiaghi A.R, Mortazavi A.R, Sajjadi K and Adib N. Formulation of Floating Tablet of Clarithromycin. 2013.
  8. Dileep. Floating Drug Delivery System. An Review: International Journal of Pharmacy and Pharmaceutical Research. 2019,16(2), 515-526.
  9. Gautam D. Mehetre, Raju R. Thenge, Rameshwar s. Cheke, Sachin D. Shinde. Novel Drug Delivery System. 2015, 154-165.
  10. Gourishyam Pasa, Prasanta Kumar Choudhary, Ghanshyam Panigrachi, Biswejeet Maharana. International Journal of Pharmaceutical Science and Drug Research. 2019, 11(1), 7-15.
  11. Hardman J.G Limbrid L.E, The Pharmacological Basis of Therapeutics. 10th edition. Godman and Gilman's; New York: Me Graov Hill; 2001.
  12. Harshvinder Singh, Shilpapahwa, Kaushal Dhamija, Vandana Arora. Formulation and Evaluation of Floating Tablets of Cimitidine. International Journal of Chem. Tech. Research. 11(9), 383-392.
  13. Havaldar V.D, Kulkarni A.S, Dias R.J, Alookar N.H and Mali K.K. Floating Matrix Tablets of Atenolol. Formulation and In-Vitro Evaluation. Asian Journal of Pharmaceutics. 2009, 286-291.
  14. Anonyms, Indian Pharmacopoeia,2018.
  15. Klausner E.A, Lavy E. Friedman M, Hoffman A. Expandable Gstroretentive Dosage Forn. J.Control. Rel. 2003, 143-162.
  16. Latha Kukati, Chittimalli K and Shaik N.B. Journal of Scientific Research. 2014, 6(3), 537-539.
  17. Manoj Kumar S. Patil. Vidyasagar G, Patil Vinayak B. International Journal of Pharmacy and Pharmaceutical Science. 1(5), 320-326.
  18. Marget Chandria R, Debjit Bhowmik, Rahi Yadav, Jayakar, K.P. Sampath Kumar. Formulation and Evaluation of oral Tablets Ibuprofen. The Pharma Journal. 1(9).
  19. Mehta RM. Pharmaceutics-I. 2udedition. Vallabh Prakashan, New Delhi, 1997
  20. Mendhan J, Denny R C, Barnas D J, Thomas M. Vogel's. Textbook of Quantitative Chemical Analysis. 6th edition. New Delhi, 2000
  21. Muralidharan Nama, Chandra Sekhar Rao, Gonugunta and Prabhakar Reddy Veerareddy. American Association of Pharmaceutical scientists Tech. 2008,9(1), 231.
  22. Niazi S.K. Handbook of Pharmaceutical Manufacturing Formulation. 1st edition, Informa Healthcare, USA, 2000, 1, 1-2.
  23. Pinak Patel. An Integral Part of Formulation Design. 2013, 3(4).
  24. Prassana Kumar Desu, Vaishnavi G, Divya K, Lakshmi U. Review Article: An Overview Preformulation studies. 1(8).
  25. Quan Zhou, Ling-Ling Zhu, Su Zeng and Wensheng Pan. World Joumal of Gastrology. 2008,14(39), 6065-6071.
  26. Raymond C Rowe, Paul J Sheskey, Paul J Weller. Handbook of Pharmaceutical excipients. 4thedition. Pharamaceutical press, USA, 2003
  27. Salve PS. Asian Journal of Research in Pharmaceutical Science. 2011,1(4),97-99.
  28. Sandip Sapkal, Mahesh B. Narkhede, Gautam D. Mehetre, Prasad V Rane. World Journal of Pharmacy and Pharmaceutical Sciences. 1(4), 1402-1412.
  29. Saripilli Rajeswari, Korallal Hair, Ramana Murthy K.V. Research Journal of Pharmacy and Technology. 2019, 12(4).
  30. Sharwaree Hardikar, Ashok Bhosale, Science Direct. 2018, 56(2), 147-157.
  31. Shiva Kumar, Shruthi Chopra, Amit Mittal, Saurabh Singh, Jaswinder Kaur, Dileep Singh Baghel, Amit Bhatina. A Comprehensive Review on Tablet Processing and Evaluation. JETIR.2018, 5(12).
  32. Singh B N Kim HK.Floating Drug Delivery System: An approach to oral controlled drug delivery via gastric retention. J. Control. Rel. 2000, 235-2599.

Reference

  1. Arifa Begum S.K, Basavu Raju. Formulation Development and Evaluation of Cimetidine floating microspheres. International Journal of Pharma Tech Research. 2013 9(2),182-192.
  2. Ashish Garg, Gupta M.M. Mouth Dissolving Tablets. Journal of Drug Delivery and Therapeutics. 2013, 3(2), 207-214.
  3. Burns SJ. Altwood D, Barnwell SG. Assessment of a Dissolution Vessel Designed for Use with Floating and Erodible Dosage Forms. Int. J. Pharm. 1998, 160,213-218.
  4. Chawla G, Gupta P, Koradia V, Bansal A. Gastroretention: A means to address regional Variability in intestinal drug abosorption. Pharm. Tech. 2003, 50-68.
  5. Chowdary K.P.R, Galibsaheb V. Asian Journal of Chemistry. 2010,22(7), 5277-5281.
  6. Dave B.S, Amin A.F. Patel M.M. Gastroretentive Drug Delivery System of Ranitidine HCI Formulation and In-Vitro Evaluation AAPS Pharm. Sci. Tech. 2004,5(2),1-6.
  7. Dehdari S, Dabirsiaghi A.R, Mortazavi A.R, Sajjadi K and Adib N. Formulation of Floating Tablet of Clarithromycin. 2013.
  8. Dileep. Floating Drug Delivery System. An Review: International Journal of Pharmacy and Pharmaceutical Research. 2019,16(2), 515-526.
  9. Gautam D. Mehetre, Raju R. Thenge, Rameshwar s. Cheke, Sachin D. Shinde. Novel Drug Delivery System. 2015, 154-165.
  10. Gourishyam Pasa, Prasanta Kumar Choudhary, Ghanshyam Panigrachi, Biswejeet Maharana. International Journal of Pharmaceutical Science and Drug Research. 2019, 11(1), 7-15.
  11. Hardman J.G Limbrid L.E, The Pharmacological Basis of Therapeutics. 10th edition. Godman and Gilman's; New York: Me Graov Hill; 2001.
  12. Harshvinder Singh, Shilpapahwa, Kaushal Dhamija, Vandana Arora. Formulation and Evaluation of Floating Tablets of Cimitidine. International Journal of Chem. Tech. Research. 11(9), 383-392.
  13. Havaldar V.D, Kulkarni A.S, Dias R.J, Alookar N.H and Mali K.K. Floating Matrix Tablets of Atenolol. Formulation and In-Vitro Evaluation. Asian Journal of Pharmaceutics. 2009, 286-291.
  14. Anonyms, Indian Pharmacopoeia,2018.
  15. Klausner E.A, Lavy E. Friedman M, Hoffman A. Expandable Gstroretentive Dosage Forn. J.Control. Rel. 2003, 143-162.
  16. Latha Kukati, Chittimalli K and Shaik N.B. Journal of Scientific Research. 2014, 6(3), 537-539.
  17. Manoj Kumar S. Patil. Vidyasagar G, Patil Vinayak B. International Journal of Pharmacy and Pharmaceutical Science. 1(5), 320-326.
  18. Marget Chandria R, Debjit Bhowmik, Rahi Yadav, Jayakar, K.P. Sampath Kumar. Formulation and Evaluation of oral Tablets Ibuprofen. The Pharma Journal. 1(9).
  19. Mehta RM. Pharmaceutics-I. 2udedition. Vallabh Prakashan, New Delhi, 1997
  20. Mendhan J, Denny R C, Barnas D J, Thomas M. Vogel's. Textbook of Quantitative Chemical Analysis. 6th edition. New Delhi, 2000
  21. Muralidharan Nama, Chandra Sekhar Rao, Gonugunta and Prabhakar Reddy Veerareddy. American Association of Pharmaceutical scientists Tech. 2008,9(1), 231.
  22. Niazi S.K. Handbook of Pharmaceutical Manufacturing Formulation. 1st edition, Informa Healthcare, USA, 2000, 1, 1-2.
  23. Pinak Patel. An Integral Part of Formulation Design. 2013, 3(4).
  24. Prassana Kumar Desu, Vaishnavi G, Divya K, Lakshmi U. Review Article: An Overview Preformulation studies. 1(8).
  25. Quan Zhou, Ling-Ling Zhu, Su Zeng and Wensheng Pan. World Joumal of Gastrology. 2008,14(39), 6065-6071.
  26. Raymond C Rowe, Paul J Sheskey, Paul J Weller. Handbook of Pharmaceutical excipients. 4thedition. Pharamaceutical press, USA, 2003
  27. Salve PS. Asian Journal of Research in Pharmaceutical Science. 2011,1(4),97-99.
  28. Sandip Sapkal, Mahesh B. Narkhede, Gautam D. Mehetre, Prasad V Rane. World Journal of Pharmacy and Pharmaceutical Sciences. 1(4), 1402-1412.
  29. Saripilli Rajeswari, Korallal Hair, Ramana Murthy K.V. Research Journal of Pharmacy and Technology. 2019, 12(4).
  30. Sharwaree Hardikar, Ashok Bhosale, Science Direct. 2018, 56(2), 147-157.
  31. Shiva Kumar, Shruthi Chopra, Amit Mittal, Saurabh Singh, Jaswinder Kaur, Dileep Singh Baghel, Amit Bhatina. A Comprehensive Review on Tablet Processing and Evaluation. JETIR.2018, 5(12).
  32. Singh B N Kim HK.Floating Drug Delivery System: An approach to oral controlled drug delivery via gastric retention. J. Control. Rel. 2000, 235-2599.

Photo
G. Hariharaputhraayyanar
Corresponding author

Department of Pharmaceutics, Adhiparasakthi College of Pharmacy, The Tamil Nadu Dr. M.G.R. Medical University, Chennai-28, Melmaruvathur 603319, Tamil Nadu, India.

Photo
T. Tamilveeran
Co-author

Department of Pharmaceutics, Adhiparasakthi College of Pharmacy, The Tamil Nadu Dr. M.G.R. Medical University, Chennai-28, Melmaruvathur 603319, Tamil Nadu, India.

Photo
D. Jothika
Co-author

Department of Pharmaceutics, Adhiparasakthi College of Pharmacy, The Tamil Nadu Dr. M.G.R. Medical University, Chennai-28, Melmaruvathur 603319, Tamil Nadu, India.

Photo
P. Lokeshwari
Co-author

Department of Pharmaceutics, Adhiparasakthi College of Pharmacy, The Tamil Nadu Dr. M.G.R. Medical University, Chennai-28, Melmaruvathur 603319, Tamil Nadu, India.

Photo
S. Rithick Raja
Co-author

Department of Pharmaceutics, Adhiparasakthi College of Pharmacy, The Tamil Nadu Dr. M.G.R. Medical University, Chennai-28, Melmaruvathur 603319, Tamil Nadu, India.

Photo
M. Sriram
Co-author

Department of Pharmaceutics, Adhiparasakthi College of Pharmacy, The Tamil Nadu Dr. M.G.R. Medical University, Chennai-28, Melmaruvathur 603319, Tamil Nadu, India.

Photo
E. Sriranjani
Co-author

Department of Pharmaceutics, Adhiparasakthi College of Pharmacy, The Tamil Nadu Dr. M.G.R. Medical University, Chennai-28, Melmaruvathur 603319, Tamil Nadu, India.

G. Hariharaputhraayyanar*, T. Tamilveeran, D. Jothika, P. Lokeshwari, S. Rithick Raja, M. Sriram, E. Sriranjani, Formulation, Development and Evaluation of Clarithromycin Floating Tablets by Using Synthetic and Natural Polymer for Eradication of Helicobacter Pylori Infection, Int. J. of Pharm. Sci., 2025, Vol 3, Issue 10, 2249-2260 https://doi.org/10.5281/zenodo.17421749

More related articles
Formulation And Evaluation of Metoprolol Succinate...
J. Santhosh Kumar, Senthil Kumar K. L., ...
Formulation and Evaluation of Polyherbal Antidiabe...
Sontakke Vinayak, Sontakke Vaishnavi, Surnar Rameshwar, Taur Dish...
Formulation and Evaluation of Herbal Nasal Spray f...
Pratham Bangar, Dr. Sachin Bhalekar, Dr. Rahul Lokhande, Ganesh L...
Citrus Shield Vitamin C And E Enriched Skin Serum...
Harshal Deshmukh, Rakshada Dhudkekar, Dr. Swati Deshmukh, ...
A New Stability Indicating Reverse Phase HPLC Method for the Simultaneous Determ...
Goutam Sen, Appalacharyulu Salapaka, N. Annapurna, N. A. Vekariya, Hemant Kumar Sharma, ...
Formulation And Evaluation of Herbal Lip Balm Using Beetroot Extract...
Pavan Sawake, Rakshada Dhudkekar, Dr. Swati Deshmukh, ...
Related Articles
Guided Growth and Early Malocclusion Correction: An Orthodontic Review...
Angha Patil, Chaya Chhabra, Simran C. Bhojwani, Khushbu Soni, Eemana Bhat, Shrushti Thakre, ...
Quality Aspects of Herbal Drug and Their Formulation: Challenges, Standards, And...
Sakshi Jadhav, Aaquil Maaz, Sakshi Kadam, Vaishnavi Kanade, Sonali Somase, ...
Formulation And Characterization of Aceclofenac Loaded Mucoadhesive Microspheres...
Jaswinder Singh, Mohit Chauhan, Anu Jindal, Rajmeet Singh, Shaveta Bhardwaj, Satvinder kaur, ...
More related articles
Formulation and Evaluation of Polyherbal Antidiabetic Churna Formulated by Jamun...
Sontakke Vinayak, Sontakke Vaishnavi, Surnar Rameshwar, Taur Disha, Tidke Satyanarayan, Saiprasad Ch...
Formulation and Evaluation of Herbal Nasal Spray for Detoxification of Tar Depos...
Pratham Bangar, Dr. Sachin Bhalekar, Dr. Rahul Lokhande, Ganesh Lamkhede, Sujal Jagnade, Sahil Janwa...
Formulation and Evaluation of Polyherbal Antidiabetic Churna Formulated by Jamun...
Sontakke Vinayak, Sontakke Vaishnavi, Surnar Rameshwar, Taur Disha, Tidke Satyanarayan, Saiprasad Ch...
Formulation and Evaluation of Herbal Nasal Spray for Detoxification of Tar Depos...
Pratham Bangar, Dr. Sachin Bhalekar, Dr. Rahul Lokhande, Ganesh Lamkhede, Sujal Jagnade, Sahil Janwa...